Navalit (Doxylamine Hydrogen Succinate, Pyridoxine Hydrochloride)

The doxylamine component blocks peripheral H1 histamine receptors, producing sedative and anti‑emetic effects that reduce the vomiting reflex. Pyridoxine (vitamin B6) acts as a co‑factor in neurotransmitter synthesis, helping to modulate central pathways that trigger nausea, especially in pregnancy.

The specific dose and dosing schedule of Navalit are determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Navalit is intended for use in pregnancy to treat morning sickness, but the decision to use it should be made by a qualified healthcare provider who weighs the potential benefits against any possible risks. Limited data are available for breastfeeding, so professional guidance is recommended.

To order Navalit, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with other anti‑emetics, Navalit combines a first‑generation antihistamine with vitamin B6, offering a dual mechanism that can be effective for pregnancy‑related nausea. Some alternatives, such as ondansetron, act on serotonin receptors. Choice of therapy depends on efficacy, safety profile, patient tolerance and clinical guidelines.

Navalit should be stored at room temperature, below 25 °C, in its original packaging. It must be kept away from moisture, direct sunlight and sources of heat. Ensure the container is tightly closed to maintain product stability throughout its shelf life.

Navalit is taken orally, usually as a tablet, with or without food as directed by the prescriber. The medication should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, hepatic dysfunction, seizures and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like rash, difficulty breathing, jaundice, unexplained seizures or irregular heartbeat.

Navalit should be avoided in individuals with known hypersensitivity to doxylamine, pyridoxine or any excipients in the formulation. Caution is advised for patients with severe hepatic impairment, uncontrolled asthma, or those taking other central nervous system depressants. Pregnant women should only use it under medical supervision.